ATE271042T1 - Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren - Google Patents

Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren

Info

Publication number
ATE271042T1
ATE271042T1 AT01902578T AT01902578T ATE271042T1 AT E271042 T1 ATE271042 T1 AT E271042T1 AT 01902578 T AT01902578 T AT 01902578T AT 01902578 T AT01902578 T AT 01902578T AT E271042 T1 ATE271042 T1 AT E271042T1
Authority
AT
Austria
Prior art keywords
pets
pyrimidine
farm animals
endothelin antagonists
endothelin
Prior art date
Application number
AT01902578T
Other languages
German (de)
English (en)
Inventor
Bernard J Banks
Adrian P Foster
Stephen P Gibson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE271042T1 publication Critical patent/ATE271042T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Treatment Of Metals (AREA)
AT01902578T 2000-02-11 2001-02-06 Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren ATE271042T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0003234.2A GB0003234D0 (en) 2000-02-11 2000-02-11 Method of treatment
PCT/IB2001/000142 WO2001058882A1 (en) 2000-02-11 2001-02-06 Use of pyrimidine endothelin antagonists in companion animals

Publications (1)

Publication Number Publication Date
ATE271042T1 true ATE271042T1 (de) 2004-07-15

Family

ID=9885465

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01902578T ATE271042T1 (de) 2000-02-11 2001-02-06 Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren

Country Status (17)

Country Link
EP (1) EP1254120B1 (tr)
JP (1) JP2003528050A (tr)
KR (1) KR20020075791A (tr)
AT (1) ATE271042T1 (tr)
AU (1) AU3043601A (tr)
CA (1) CA2398007A1 (tr)
DE (1) DE60104283T2 (tr)
DK (1) DK1254120T3 (tr)
ES (1) ES2222975T3 (tr)
GB (1) GB0003234D0 (tr)
HU (1) HUP0204370A3 (tr)
IL (1) IL150488A0 (tr)
NZ (1) NZ519002A (tr)
PT (1) PT1254120E (tr)
TR (1) TR200401815T4 (tr)
WO (1) WO2001058882A1 (tr)
ZA (1) ZA200206343B (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8647660B2 (en) 2004-12-29 2014-02-11 Hill's Pet Nutrition, Inc. Combination of limited nutrients and enhanced dietary antioxidants to impart improved kidney health
JP5451065B2 (ja) * 2005-04-19 2014-03-26 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 腎疾患の予防および治療のための方法および組成物
CN102770195B (zh) * 2010-02-25 2015-03-04 弗·哈夫曼-拉罗切有限公司 高亲和性化合物结合常数的测定方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE201202T1 (de) * 1995-12-20 2001-06-15 Yamanouchi Pharma Co Ltd Arylethensulfonamid-derivate und diese enthaltende medikamente
WO1998057938A1 (fr) * 1997-06-19 1998-12-23 Yamanouchi Pharmaceutical Co., Ltd. Derives d'alcanesulfonamide inferieur substitue et composition pharmaceutique les contenant

Also Published As

Publication number Publication date
AU3043601A (en) 2001-08-20
HUP0204370A3 (en) 2003-07-28
PT1254120E (pt) 2004-10-29
ES2222975T3 (es) 2005-02-16
HUP0204370A2 (en) 2003-05-28
IL150488A0 (en) 2002-12-01
TR200401815T4 (tr) 2004-08-23
ZA200206343B (en) 2003-08-08
WO2001058882A1 (en) 2001-08-16
DE60104283D1 (de) 2004-08-19
KR20020075791A (ko) 2002-10-05
EP1254120B1 (en) 2004-07-14
CA2398007A1 (en) 2001-08-16
NZ519002A (en) 2004-06-25
GB0003234D0 (en) 2000-04-05
DK1254120T3 (da) 2004-10-04
JP2003528050A (ja) 2003-09-24
DE60104283T2 (de) 2004-11-18
EP1254120A1 (en) 2002-11-06

Similar Documents

Publication Publication Date Title
ATE287217T1 (de) Verwendung von kreatin als futterzusatz
NL300149I1 (nl) Samenstelling met insecticide werking tegen vlooien bij zoogdieren, in het bijzonder honden en katten.
ATE439762T1 (de) Verwaltungssystem von lebendem inventar und verfahren zur trenngewichtfütterung
HUP0104782A2 (hu) Eljárás állatkedvencek aktivitásának fokozására
EA200401284A1 (ru) Замещённые бензазолы и их применение в качестве ингибиторов киназы raf
ID28812A (id) Enzima-enzima antimikroba di dalam pakan hewan
DE60214080D1 (de) Medizinische Verwendung thyromimetischer Verbindungen gegen Haarausfall und Zusammensetzungen
GB0406426D0 (en) Chew
DE602004019995D1 (de) Verwendung von n-arylhydrazinderivaten für die bekämpfung von schädlingen in und an tieren
ATE481103T1 (de) Derivate von 2-(8,9-dioxo-2,6- diazabicyclo(5.2.0)non-1(7)-en-2- yl)alkylphosphonsäure und deren verwendung als n- methyl-d-aspartat- (nmda-) rezeptorantagonisten
BR9909408A (pt) Tratamento de animais com compostos de diidroxiquinolina
ATE271042T1 (de) Verwendung von pyrimidin-endothelin-antagonisten in haus- und nutztieren
DE50000911D1 (de) Hufeisenartiger, plattenförmiger Hufbeschlag aus Kunststoff
RU2001117033A (ru) Вещества, проявляющие антимикробную, антигрибковую, антипротозойную активности
HUP9900833A2 (hu) N-fenil-pirazolt tartalmazó bolha és kullancs elleni nyakörv kutyák és macskák számára
DE502005007641D1 (de) Steigerung des proteinanteils tierischer organismen
BRPI0401575A (pt) Cerca móvel controlável para gado
ATE31306T1 (de) Chinazolinon-derivate wirksam gegen coccidiosis.
IT1307023B1 (it) Articoli per la masticazione di animali.
SE0402370D0 (sv) Arrangement and methods for automatic milking of animals
KR20200008202A (ko) 반려견 교배 어플
ATE120334T1 (de) Streu für die tierhaltung.
DK0877598T3 (da) Anthelmintisk pasta
Pain My pet possum
ATE332647T1 (de) Verwendung von quillaja-pulver

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1254120

Country of ref document: EP

REN Ceased due to non-payment of the annual fee